<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/16B653E2-0DEA-4EC3-BEB0-B755754726BD"><gtr:id>16B653E2-0DEA-4EC3-BEB0-B755754726BD</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Buckley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F131"><gtr:id>3437B758-BD22-4317-B53A-4FD69FB549EB</gtr:id><gtr:title>The role of fibroblasts in the regulation of leucocyte behaviour in chronic inflammatory arthritis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/131</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>914021</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Cellzome Ltd</gtr:department><gtr:description>CellZome</gtr:description><gtr:id>437FDF20-E15B-4E30-90A1-8527C752D884</gtr:id><gtr:impact>This collaboration led to an MRC Industrial partnership grnat G0800754</gtr:impact><gtr:outcomeId>BFB796486E7-1</gtr:outcomeId><gtr:partnerContribution>Reagents</gtr:partnerContribution><gtr:piContribution>Provision of samples for kinase assays</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Cellzome Ltd</gtr:department><gtr:description>BEAT-RA Experimental Arthritis Center</gtr:description><gtr:id>D10CA77E-985A-45E3-8845-1B63FD5C7604</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>mhXqBdyL4YP-1</gtr:outcomeId><gtr:piContribution>Collaboation with CellZome to investiagte early Phase2a studies</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio 4 Inflammation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9A95B33E-B372-4F47-AC1D-45966D4F9EB6</gtr:id><gtr:impact>http://www.bbc.co.uk/radio4/inflamedresponse/pip/archive/

Public awarenss of inflamamtion</gtr:impact><gtr:outcomeId>A610FB4EDA4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Publication in arthritis today</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>22FEE2F9-8B53-4688-A872-768E6D24D943</gtr:id><gtr:impact>http://www.arc.org.uk/news/arthritistoday/139_6.asp

Well received by arthritis community</gtr:impact><gtr:outcomeId>5DCFF4191A3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>9778C3DC-50DF-440E-8AD0-F7FE4241DA2A</gtr:id><gtr:outcomeId>2E6B57334A90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP6 grant</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>74E237C3-6778-43AF-819E-D2D96B08A6BE</gtr:id><gtr:outcomeId>83A02A8C6350</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Industrial Partnership</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>063830C2-A091-4154-B93C-D7A54917D68B</gtr:id><gtr:outcomeId>875669BF51E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (The role of the novel fibroblast receptor CD248 (Endosialin) in lymphoid tissue expansion, remodelling and repair)</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>994F6463-5445-451A-ACE7-88F6D510C14B</gtr:id><gtr:outcomeId>3158D4E0EE70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A6E22A7E-495F-40D5-B1AA-03FED957910C</gtr:id><gtr:title>Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5a81dcc15e7c7436b822c282b3f8f5"><gtr:id>0f5a81dcc15e7c7436b822c282b3f8f5</gtr:id><gtr:otherNames>Bekiaris V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>82B0F7FF7C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8065E4E7-36F6-4EFA-965A-F12C99CD7244</gtr:id><gtr:title>Targeting stromal cells in chronic inflammation.</gtr:title><gtr:parentPublicationTitle>Discovery medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a76a305e99311abb6cb889145b2c5d8"><gtr:id>1a76a305e99311abb6cb889145b2c5d8</gtr:id><gtr:otherNames>Filer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1539-6509</gtr:issn><gtr:outcomeId>7F55250EB92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56E0BCDF-2834-47B2-8F4A-9BC284D6B96C</gtr:id><gtr:title>Annexin-1 modulates T-cell activation and differentiation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcb459050d58e98d36727c0f24490057"><gtr:id>fcb459050d58e98d36727c0f24490057</gtr:id><gtr:otherNames>D'Acquisto F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>B4B0FEBCE1B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D20F1C2-D7F8-4A96-8610-E921360AFFEA</gtr:id><gtr:title>Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e01eb662ec268773012a89f94a2856"><gtr:id>50e01eb662ec268773012a89f94a2856</gtr:id><gtr:otherNames>Parsonage G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>FE8641C1DAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13602A28-B01C-4C04-B704-53C75D816B8E</gtr:id><gtr:title>Serum amyloid P and fibrosis in systemic sclerosis: comment on the article by Tennent et al.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b243250c2501af625ef29dcf716230"><gtr:id>76b243250c2501af625ef29dcf716230</gtr:id><gtr:otherNames>Pilling D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>6B5A93A4ADF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20EADF4D-6498-4026-89D4-4995A3B2BF9E</gtr:id><gtr:title>Targeting the stromal microenvironment in chronic inflammation.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a76a305e99311abb6cb889145b2c5d8"><gtr:id>1a76a305e99311abb6cb889145b2c5d8</gtr:id><gtr:otherNames>Filer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>41554D269C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB909957-7183-41CE-BE4F-C01C3C5A01B6</gtr:id><gtr:title>The assessment of T-cell apoptosis in synovial fluid.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3716f4b58cafc5a191549295d646105e"><gtr:id>3716f4b58cafc5a191549295d646105e</gtr:id><gtr:otherNames>Raza K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>23A724D3FB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D381E15-1AE4-4A17-B664-501A3645A5C7</gtr:id><gtr:title>Immune interactions in hepatic fibrosis.</gtr:title><gtr:parentPublicationTitle>Clinics in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0a9347c9d869e5d5869adb3a546ea54"><gtr:id>a0a9347c9d869e5d5869adb3a546ea54</gtr:id><gtr:otherNames>Holt AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1089-3261</gtr:issn><gtr:outcomeId>1C55720A9A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>072408BF-B07F-4040-AE83-04BCFEC47232</gtr:id><gtr:title>CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87298eb25e04df0efe4e16f397cbf682"><gtr:id>87298eb25e04df0efe4e16f397cbf682</gtr:id><gtr:otherNames>Chan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>B841DC1FD88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB51EAF-3FA7-4841-A39C-F4DBB1CDC764</gtr:id><gtr:title>Modulation of endothelial responses by the stromal microenvironment: effects on leucocyte recruitment.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>9FDE58D4FF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7E16B82-214F-4305-9EFD-8F17362218AF</gtr:id><gtr:title>Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a96b012457623cf527842060642b7ad3"><gtr:id>a96b012457623cf527842060642b7ad3</gtr:id><gtr:otherNames>Buckley CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>F5FA43CDFB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>269877EA-85D2-4039-A571-08331DEB84CF</gtr:id><gtr:title>CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78294fa7e556472f7e89779e9f44c23"><gtr:id>f78294fa7e556472f7e89779e9f44c23</gtr:id><gtr:otherNames>Manzo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>3B03ED40562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6082FA3F-59F5-4C64-8579-207CCE3624EC</gtr:id><gtr:title>Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>4F4031675F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B2088A-D605-447A-BCDA-E60E712F104B</gtr:id><gtr:title>Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3716f4b58cafc5a191549295d646105e"><gtr:id>3716f4b58cafc5a191549295d646105e</gtr:id><gtr:otherNames>Raza K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>94466EC6B42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>545A3529-7225-47A2-8526-E75EA197366B</gtr:id><gtr:title>Resolution of inflammation: state of the art, definitions and terms.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4117dfc46b467fa4eca3d43b9371f31c"><gtr:id>4117dfc46b467fa4eca3d43b9371f31c</gtr:id><gtr:otherNames>Serhan CN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>6456468051E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>241353EA-9EEF-45F9-8862-C843527F0E6D</gtr:id><gtr:title>Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbff024946625fe40da562d041f695e"><gtr:id>8cbff024946625fe40da562d041f695e</gtr:id><gtr:otherNames>Palendira U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>2C420D547A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C836B62B-8AF4-4E27-90C1-DD9CB7080270</gtr:id><gtr:title>Treating very early rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3716f4b58cafc5a191549295d646105e"><gtr:id>3716f4b58cafc5a191549295d646105e</gtr:id><gtr:otherNames>Raza K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1521-6942</gtr:issn><gtr:outcomeId>4D655095A12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>949F442F-B455-4474-B862-5DF1DC0DF029</gtr:id><gtr:title>Fibroblasts as novel therapeutic targets in chronic inflammation.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f450c313a516c0d5688f261bd7fc1b4"><gtr:id>9f450c313a516c0d5688f261bd7fc1b4</gtr:id><gtr:otherNames>Flavell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>F6D27D2F50B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EE99D66-5A6E-4694-B981-61884E34D92B</gtr:id><gtr:title>Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189e6bc991e4a601e3505b421420837d"><gtr:id>189e6bc991e4a601e3505b421420837d</gtr:id><gtr:otherNames>Smith E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>04CA0DA1AA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C92871FB-77CC-4B68-9684-A52B1D324E50</gtr:id><gtr:title>Skin cancer in psoriatic arthritis treated with anti-TNF therapy.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42d33b2ee545e39599ad62cd006aa8ac"><gtr:id>42d33b2ee545e39599ad62cd006aa8ac</gtr:id><gtr:otherNames>Sheppard J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>99E890748DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B983D085-4FDC-4755-9C65-F3F517249BF3</gtr:id><gtr:title>CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4eeb2d916603bac88cdc1b3ca0871f9f"><gtr:id>4eeb2d916603bac88cdc1b3ca0871f9f</gtr:id><gtr:otherNames>Lax S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>1EDB27703F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57531EB5-0962-46A9-B92B-9BD60C250283</gtr:id><gtr:title>Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a76a305e99311abb6cb889145b2c5d8"><gtr:id>1a76a305e99311abb6cb889145b2c5d8</gtr:id><gtr:otherNames>Filer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>13D7F25E6EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D58B2259-6267-482F-84F4-DF633FB1A050</gtr:id><gtr:title>Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d98bf3954a69fc156c27af9fb0725e"><gtr:id>88d98bf3954a69fc156c27af9fb0725e</gtr:id><gtr:otherNames>Hardy RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>3D743115437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7479EB5E-B69D-41F5-97E2-FB3BE641DA26</gtr:id><gtr:title>Interaction between integrin alpha9beta1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>3D453489142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E2C4EBB-5683-4974-BCF2-F7920B44210F</gtr:id><gtr:title>Local and systemic glucocorticoid metabolism in inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3047042ff071e80e8f4f468fd3c2cf31"><gtr:id>3047042ff071e80e8f4f468fd3c2cf31</gtr:id><gtr:otherNames>Hardy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>E243624AE7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DAAFD7E-DD88-4C28-9D79-E50BB305884E</gtr:id><gtr:title>Mesenchymal stem cells: the fibroblasts' new clothes?</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75514f8f493721a6cccc79f8b42738d1"><gtr:id>75514f8f493721a6cccc79f8b42738d1</gtr:id><gtr:otherNames>Haniffa MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>FZU8tywFdWY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F418000-DCD8-41CA-B75F-9E7CBE69994B</gtr:id><gtr:title>A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1467a3b47d9f7eef82187fe2be8d539e"><gtr:id>1467a3b47d9f7eef82187fe2be8d539e</gtr:id><gtr:otherNames>Lally F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>7574F1548E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD79A5B6-EC7F-4D82-97A6-DAA25B64411D</gtr:id><gtr:title>Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f703b15dc07402323748f3f2d9d163"><gtr:id>85f703b15dc07402323748f3f2d9d163</gtr:id><gtr:otherNames>Kumar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>6FE6854DE58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEDDB358-39D0-4A82-9322-4B04D7C72967</gtr:id><gtr:title>Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534a299c44882e55b3ea88c8fa191493"><gtr:id>534a299c44882e55b3ea88c8fa191493</gtr:id><gtr:otherNames>Scheel-Toellner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn><gtr:outcomeId>8AA0ED78224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8D083E6-8D34-4CF6-AAC5-A155FA5517C0</gtr:id><gtr:title>Anti-collagen type II antibodies in patients with very early synovitis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3716f4b58cafc5a191549295d646105e"><gtr:id>3716f4b58cafc5a191549295d646105e</gtr:id><gtr:otherNames>Raza K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>4C113C7387B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DC56776-5949-411D-BF74-A32D8FE0773C</gtr:id><gtr:title>Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87298eb25e04df0efe4e16f397cbf682"><gtr:id>87298eb25e04df0efe4e16f397cbf682</gtr:id><gtr:otherNames>Chan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>CADFC964CA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09841C37-0C4C-435C-8A22-16D25E5A408A</gtr:id><gtr:title>A role for the integrin alpha6beta1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc31252be239b748664879198afe47d"><gtr:id>9bc31252be239b748664879198afe47d</gtr:id><gtr:otherNames>Haworth O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>553D63A766F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B823057-14CC-47FA-BD7F-FA368E334D6D</gtr:id><gtr:title>Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcb459050d58e98d36727c0f24490057"><gtr:id>fcb459050d58e98d36727c0f24490057</gtr:id><gtr:otherNames>D'Acquisto F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>7BFDAF3A6F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F22FFF95-3311-4A75-8E3E-1DAEC4BE03E9</gtr:id><gtr:title>Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>DaSxBA8XtvC</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/131</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>